Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19 Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Reyno, L
  • Seymour, L
  • Tu, DS
  • Dent, S
  • Gelmon, K
  • Walley, B
  • Pluzanska, A
  • Gorbunova, V
  • Garin, A
  • Jassem, J
  • Pienkowski, T
  • Dancey, J
  • Pearce, L
  • MacNeil, M
  • Marlin, S
  • Lebwohl, D
  • Voi, M
  • Pritchard, Kathleen

publication date

  • January 15, 2004